a company which engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations
Industry Biotechnology
A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.
Ticker / NAME | Correlation To RPTX | 1D Price Change % | ||
---|---|---|---|---|
RPTX | 100% | -8.75% | ||
INO - RPTX | 47% Loosely correlated | -8.84% | ||
BCYC - RPTX | 47% Loosely correlated | +0.13% | ||
EDIT - RPTX | 44% Loosely correlated | +2.70% | ||
NTLA - RPTX | 35% Loosely correlated | -1.87% | ||
FOLD - RPTX | 35% Loosely correlated | -0.10% | ||
More |